RxDoctor Payments Data

Scott Magnuson, MD

Pain Medicine · Coeur D Alene, IDNPI 1174593404

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,177 of the $8,547 with a category attached, or 72.3%. It is spread thinly across 31 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2019 at $2,970 and has fallen 80.0% since, to $593 in 2025.

$8,547in general payments, 2019–2025

Across 233 payments — averaging $36.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$2K
  • Vertiflex, Inc.$2K
  • Si-bone, Inc.$958
  • Johnson & Johnson$649
  • Medtronic$613
  • AbbVie$398
  • plus $2K from 25 others
$7,500in research payments, 2019–2025

Across 1 payment — averaging $7500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Nalu Medical, Inc.$8K

What the payments were for

  • Travel & lodging$2,37028%
  • Food & beverage$6,17772%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,547 in reported general payments places this provider in the 70th percentile of 32 pain medicine providers in Idaho.

See all pain medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$150,284
Medicare patients
396
Services billed
3,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen11$62,709
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen89$1,736
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$723
Morphine Sulfate13$524
Morphine Sulfate ErMorphine Sulfate12$436
Gabapentin32$401
Methadone Hcl15$351
Tizanidine Hcl18$331
Pregabalin15$315
Oxycodone Hcl11$187
Tramadol Hcl21$157
Methocarbamol16$111

Paid to pharmacies, not to this prescriber.

Other pain medicine in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →